Meet the 72 Industry 4.0 Startups most valued by the BIND 4.0 Partner Companies and the Finalists for the 5th Edition of the Program
20 de las seleccionadas proceden de Euskadi, 20 son estatales y 32 internacionales
The Basque Government participates in the Research and production project for the vaccine against COVID 19, together with Harvard and the company VIRALGEN
Tapia highlights that, once Harvard advances with the vaccine, the Basque Country is ready to take on this opportunity that represents a unique health, social and business advance
VIVEbiotech SL new member of the Board of Directors of the Spanish Bioindustry Association (AseBio)
AseBio brings together more than 730 companies that employ almost 100,000 people and invest more than € 400 million in R&D
VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan
in 2021 VIVEbiotech will be able to produce lentiviral vectors for advanced clinical trials
VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office
LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the genome of cells.
In Cannes, the SPRI Group General Manager receives the Financial Times award for the Basque Country as an attractive region for foreign investment
four aspects of the Invest in the Basque Country strategy of the SPRI Group and the Basque Government have received awards
Columbus launches a €70 million fund for biomedicine
With the new investment fund, the managers plan to build two new plants in San Sebastian
Bind 4.0’s startup Hupi opens office in the Basque Country
France's Hupi, one of the startups that took part in Bind 4.0's first edition, has opened an office in San Sebastian, in the Basque Country.